These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.

View All HCPCS Sections

• J0013

  Esketamine, nasal spray, 1 mg

• J0120

  Injection, tetracycline, up to 250 mg

• J0121

  Injection, omadacycline, 1 mg

• J0122

  Injection, eravacycline, 1 mg

• J0129

  Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

• J0130

  Injection abciximab, 10 mg

• J0131

  Injection, acetaminophen, not otherwise specified,10 mg

• J0132

  Injection, acetylcysteine, 100 mg

• J0133

  Injection, acyclovir, 5 mg

• J0134

  Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg

• J0135

  Injection, adalimumab, 20 mg

• J0136

  Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg

• J0137

  Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg

• J0138

  Injection, acetaminophen 10 mg and ibuprofen 3 mg

• J0139

  Injection, adalimumab, 1 mg

• J0150

  Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)

• J0151

  Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)

• J0153

  Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)

• J0162

  Injection, epinephrine (fresenius), not therapeutically equivalent to j0165, 0.1 mg

• J0163

  Injection, epinephrine in sodium chloride (endo), 0.1 mg

• J0164

  Injection, epinephrine in sodium chloride (baxter), 0.1 mg

• J0165

  Injection, epinephrine, not otherwise specified, 0.1 mg

• J0166

  Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mg

• J0167

  Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mg

• J0168

  Injection, epinephrine (international medication systems), not therapeutically equivalent to j0165, 0.1 mg

• J0169

  Injection, epinephrine (adrenalin), not therapeutically equivalent to j0165, 0.1 mg

• J0171

  Injection, adrenalin, epinephrine, 0.1 mg

• J0172

  Injection, aducanumab-avwa, 2 mg

• J0173

  Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg

• J0174

  Lecanemab-irmb, for intravenous injection, 1 mg

• J0175

  Injection, donanemab-azbt, 2 mg

• J0177

  Injection, aflibercept hd, 1 mg

• J0178

  Injection, aflibercept, 1 mg

• J0179

  Injection, brolucizumab-dbll, 1 mg

• J0180

  Injection, agalsidase beta, 1 mg

• J0184

  Injection, amisulpride, 1 mg

• J0185

  Injection, aprepitant, 1 mg

• J0190

  Injection, biperiden lactate, per 5 mg

• J0200

  Injection, alatrofloxacin mesylate, 100 mg

• J0202

  Injection, alemtuzumab, 1 mg

• J0205

  Injection, alglucerase, per 10 units

• J0206

  Injection, allopurinol sodium, 1 mg

• J0207

  Injection, amifostine, 500 mg

• J0208

  Injection, sodium thiosulfate (pedmark), 100 mg

• J0209

  Injection, sodium thiosulfate (hope), 100 mg

• J0210

  Injection, methyldopate hcl, up to 250 mg

• J0211

  Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)

• J0215

  Injection, alefacept, 0.5 mg

• J0216

  Injection, alfentanil hydrochloride, 500 micrograms

• J0217

  Injection, velmanase alfa-tycv, 1 mg

---

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT^® is a registered trademark of the American Medical Association (AMA). All rights reserved.